Catalyst Wire Dossier Catalyst Wire Dossier

SMOFlipid 20%

· Fresenius Kabi
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SMOFlipid 20%, covering 2010-08-27 to 2022-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants [Phase 3]

See pricing